SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-021567
Filing Date
2017-01-27
Accepted
2017-01-27 15:16:02
Documents
2
Group Members
PROCAR ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D d338629dsc13d.htm SC 13D 88301
2 EX-99.1 d338629dex991.htm EX-99.1 2748
  Complete submission text file 0001193125-17-021567.txt   92713
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Subject) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88836 | Film No.: 17553361
SIC: 2834 Pharmaceutical Preparations